Literature DB >> 11144371

Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up.

A Patja1, I Davidkin, T Kurki, M J Kallio, M Valle, H Peltola.   

Abstract

BACKGROUND: Several disorders have been attributed to measles-mumps-rubella (MMR) vaccination during the past decade. The aim of this prospective follow-up study was to identify serious adverse events causally related to MMR vaccination.
METHODS: When the MMR vaccination program was launched in Finland in 1982, a countrywide surveillance system was set up to detect serious adverse events associated with MMR. To obtain detailed case histories vaccinees' clinical charts were reviewed. Serum samples were analyzed to trace concurrent infections.
SETTING: All hospitals and health centers in Finland from 1982 through 1996.
RESULTS: Immunization of 1.8 million individuals and consumption of almost 3 million vaccine doses by the end of 1996 gave rise to 173 potentially serious reactions claimed to have been caused by MMR vaccination. In all, 77 neurologic, 73 allergic and 22 miscellaneous reactions and 1 death were reported, febrile seizure being the most common event. However, 45% of these events proved to be probably caused or contributed by some other factor, giving an incidence of serious adverse events with possible or indeterminate causal relation with MMR vaccination of 5.3 per 100,000 vaccinees or 3.2 per 100,000 vaccine doses.
CONCLUSIONS: Causality between immunization and a subsequent untoward event cannot be estimated solely on the basis of a temporal relation. Comprehensive analysis of the reported adverse reactions established that serious events causally related to MMR vaccine are rare and greatly outweighed by the risks of natural MMR diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11144371     DOI: 10.1097/00006454-200012000-00002

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  32 in total

1.  MMR vaccine: the continuing saga.

Authors:  D Elliman; H Bedford
Journal:  BMJ       Date:  2001-01-27

2.  MMR vaccine--worries are not justified.

Authors:  D A Elliman; H E Bedford
Journal:  Arch Dis Child       Date:  2001-10       Impact factor: 3.791

Review 3.  Ethical debate: Vaccination against mumps, measles, and rubella: is there a case for deepening the debate? How safe is MMR vaccine?

Authors:  T Heller
Journal:  BMJ       Date:  2001-10-13

Review 4.  Detection of persistent measles virus infection in Crohn's disease: current status of experimental work.

Authors:  S Ghosh; E Armitage; D Wilson; P D Minor; M A Afzal
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

Review 5.  MMR vaccination and autism : what is the evidence for a causal association?

Authors:  Kreesten M Madsen; Mogens Vestergaard
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

6.  A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety.

Authors:  Peter I Folb; Ewa Bernatowska; Robert Chen; John Clemens; Alex N O Dodoo; Susan S Ellenberg; C Patrick Farrington; T Jacob John; Paul-Henri Lambert; Noni E Macdonald; Elizabeth Miller; David Salisbury; Heinz-J Schmitt; Claire-Anne Siegrist; Omala Wimalaratne
Journal:  Am J Public Health       Date:  2004-11       Impact factor: 9.308

7.  Measles, mumps, rubella (MMR) vaccine.

Authors:  A P Dubey; S Banerjee
Journal:  Indian J Pediatr       Date:  2003-07       Impact factor: 1.967

8.  Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017.

Authors:  John R Su; Penina Haber; Carmen S Ng; Paige L Marquez; Graça M Dores; Silvia Perez-Vilar; Maria V Cano
Journal:  Vaccine       Date:  2019-12-20       Impact factor: 3.641

9.  Measles, mumps and rubella (MMR) vaccination has no effect on cognitive development in children - the results of the Polish prospective cohort study.

Authors:  Dorota Mrozek-Budzyn; Agnieszka Kiełtyka; Renata Majewska; Małgorzata Augustyniak
Journal:  Vaccine       Date:  2013-04-12       Impact factor: 3.641

10.  Hypersensitivity reactions to human papillomavirus vaccine in Australian schoolgirls: retrospective cohort study.

Authors:  Liew Woei Kang; Nigel Crawford; Mimi L K Tang; Jim Buttery; Jenny Royle; Michael Gold; Christine Ziegler; Patrick Quinn; Sonja Elia; Sharon Choo
Journal:  BMJ       Date:  2008-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.